List of companies in Novo A/S's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
AMSilk is a Munich-based synthetic biology company that produces fibers made from the same protein as spider silk. | ||||||
Inogen is a Goleta, California-based company founded in 2001. They develop and manufacture lightweight, portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. | ||||||
IO Biotech is a cancer Vaccines founded in 2014 by Mai-Britt Zocca, PhD, Professor Mads Hald Andersen, Anders Ljungqvist, Professor MD PhD Inge Marie Svane and Professor Per Thor Straten. | ||||||
Hemab Therapeutics is pioneering the first preventative treatments for rare bleeding and thrombotic disorders to ensure no patient is ever left behind | ||||||
Oral antifungal therapy developer to treat life-threatening rare fungal infections | ||||||
Precirix is a private, clinical-stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by designing and developing novel radiopharmaceuticals, using camelid-derived single-domain antibodies (sdAb) labeled with radioisotopes. | ||||||
Developer of antibody-drug conjugates (ADCs) for cancer treatment. | ||||||
Muna develops transformative therapeutics to preserve brain function and enhance resilience to neurodegenerative diseases | ||||||
Engimmune Therapeutics is a platform engineering next-generation T cell receptor therapies founded in 2021 by Søren Mouritsen. | ||||||
NMD Pharma is a small Molecule Drug Discovery founded in 2015. | ||||||
Small molecule MKK4 inhibitors developer to treat acute and chronic liver diseases. | ||||||
Asgard Therapeutics is a cancer Immunotherapy founded in 2018. | ||||||
ReViral is a biotechnology firm developing antiviral treatments for patients founded in 2011. | ||||||
AFYX Therapeutics is a topical Drug Delivery for Mucosal Diseases founded in 2013. | ||||||
Innovative therapeutic drugs to treat inflammatory, metabolic and liver diseases. | ||||||
Adaptive immune therapy capable of targeting immunosuppressive genes of ancient retroviruses | ||||||
Oral macrocycle drug discovery platform. | ||||||
Asceneuron is a clinical-stage biotech company. | ||||||
Myricx Bio is an antibody-drug conjugate (ADC) payload platform founded in 2019. | ||||||
Bactolife is a producer of gut health binding proteins founded in 2017. | ||||||
Acacia Pharma is a small Molecules founded in 2006. | ||||||
Acesion Pharma is a therapy to treat atrial fibrillation (AF founded in 2011. | ||||||
HPNow is a purification and disinfection technology founded in 2015. | ||||||
Biopharmaceutical firm providing oral treatments for retinal vascular diseases. | ||||||
Developer of oral, small molecule degrades for extracellular disease-causing proteins. |
